TCS, HDFCBANK, SBI Liquid Fund (G)
Aurobindo Pharma Ltd.
Aurobindo Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 31 05 2021 | Audited Results |
| 12 08 2021 | Interim Dividend & Quarterly Results |
| 08 11 2021 | Quarterly Results & Second Interim Dividend |
| 09 02 2022 | Third Interim Dividend & Quarterly Results |
| 30 05 2022 | Audited Results & Fourth Interim Dividend |
| 11 08 2022 | Quarterly Results |
| 12 11 2022 | Quarterly Results |
| 09 02 2023 | Quarterly Results & Interim Dividend |
| 27 05 2023 | Audited Results |
| 12 08 2023 | Quarterly Results |
| 09 11 2023 | Interim Dividend & Quarterly Results |
| 10 02 2024 | Interim Dividend |
| 09 11 2024 | Quarterly Results |
| 06 02 2025 | Quarterly Results |
News
No News data available
